Bisbenzimidazol Bağlayıcı İçeren Biyolojik Aktif Aren Rutenyum Bileşiğinin Sentezi ve Termal Bozunmasının Belirlenmesi

Bu çalışmada [Ru4(p-cymene)4(μ2-NՈN)2(μ4-OOՈOO)2][CF3SO3)4] (NՈN = Bütilen-1,4-bisbenzimidazol (bbim)) genel formülüne sahip biyolojik aktif tetranükleer aren rutenyum kompleks bileşiği, Ru2(p-cymene)2 (μ4-OOՈOO)Cl2 (OOՈOO = 5,8-dioxido-1,4-naphtoquinonato (donq))'nun gümüş triflorometansülfonat ile reaksiyona sokulması, ardından karşılık gelen NՈN bağlayıcılarının eklenmesi ile hazırlanmıştır. Biyolojik aktif aren rutenyum bileşiği IR, UV-VIS, 1H, 13C NMR spektroskopisi ve ESI-MS spektrometresi dahil standart tekniklerle karakterize edildi. Aren rutenyum bileşiğinin termal bozunma ölçüm verileri incelendi. Bu ölçümler Termogravimetrik analiz (TGA) ve Diferansiyel termal analiz (DTA) teknikleri ile yapıldı.

Anahtar Kelimeler:

Aren rutenyum, Bisbenzimidazol, Supramoleküler kimya, Termal bozulma

Synthesis and Determination of Thermal Decomposition of Biological Active Arene Ruthenium Compound Containing Bisbenzimidazole Linker

In this study, [Ru4(p-cymene)4(μ-NՈN)2(μ4-OOՈOO)2][CF3SO3)4] (NՈN = Butylene-1,4-bisbenzimidazole (bbim)) biologically active tetranuclear arene complex compound, reacting Ru2(p-cymene)2(μ4- OOՈOO) Cl2 (OOՈOO = 5,8-dioxido-1,4-naphtoquinonato (donq)) with silver trifluoromethanesulfonate, followed by the addition of the corresponding NՈN linkers. The biologically active arene ruthenium compound was characterized by standard techniques including IR, UV-VIS, 1H NMR, 13C NMR spectroscopy and ESI-MS spectrometry. Thermal decomposition measurement data of arene ruthenium compound were examined. These measurements were made by Thermogravimetric analysis (TGA) and Differential thermal analysis (DTA) techniques.

Keywords:

Arene ruthenium, Bisbenzimidazole, Supramolecular chemistry, Thermal decomposition,

PDF

___

[1] B. Rosenbeng, L. Vancamp, J. E. Trosko, and V. H. Mansour, “Nature,” Nature, vol. 222, pp. 285–286, 1969.
[2] E. Orhan, A. Garci, B. Therrien, "Coordination-driven self-assembly of arene ruthenium metalla-rectangles," Inorganica Chimica Acta, vol. 461, pp. 78–83, 2017.
[3] E. Orhan, A. Garci, T. Riedel, P. J. Dyson, B. Therrien, " Cytotoxicity of arene ruthenium metalla-rectangles incorporating bis-pyridyl diimide linkers," Journal of Organometallic Chemistry, vol. 815-816, pp. 53-58, 2016.
[4] M. Galanski, M. A. Jakupec, and B. K. Keppler, “Update of the Preclinical Situation of Anticancer Platinum Complexes : Novel Design Strategies and Innovative Analytical Approaches,” Curr. Med. Chem., vol. 12, pp. 2075–2094, 2005.
[5] E. Orhan, A. Garci, T. Riedel, M. Saudani, P. J. Dyson, B. Therrien, "Cytotoxic double arene ruthenium metalla-cycles that overcome cisplatin resistance," Journal of Organometallic Chemistry, vol. 803, pp. 39-44, 2016.
[6] C. S. Allardyce and P. J. Dyson, “Ruthenium in Medicine : Current Clinical Uses and Future Prospects,” Platin. Met. Rev., vol. 45, no. 2, pp. 62–69, 2001.
[7] I. Kostova, “Ruthenium Complexes as Anticancer Agents,” Curr. Med. Chem., vol. 13, pp. 1085–1107, 2006.
[8] C. S. Allardyce, A. Dorcier, C. Scolaro, and P. J. Dyson, “Development of organometallic (organo-transition metal) pharmaceuticals,” Bioorganometallic Chem., vol. 19, pp. 1–10, 2005.
[9] E. Orhan, A. Garci, B. Therrien, "Flexible arene ruthenium metalla-prisms," Inorganica Chimica Acta, vol. 438, pp. 5–9, 2015.
[10] A. Garci, J. P. Mbakidi, V. Chaleix, V. Sol, E. Orhan, B. Therrien, "Tunable Arene Ruthenium Metallaprisms to Transport, Shield, and Release Porphin in Cancer Cells," Organometallics, vol. 34, pp. 4138−4146, 2015.
[11] A. Garci, A. A. Dobrov, T. Riedel, E. Orhan, P. J. Dyson, V. B. Arion, B. Therrien, "Strategy to optimize the biological activity of arene ruthenium metalla-assemblies," Organometallics, vol. 33, pp. 3813−3822, 2014.
[12] A. A. Hummer et al., “X-ray absorption near edge structure spectroscopy to resolve the in vivo chemistry of the redox-active Indazolium trans - [ tetrachlorobis ( 1H- indazole ) ruthenate ( III )] ( KP1019 ),” J. Med. Chem., vol. 56, pp. 1182, 2013.
[13] G. Tamasi et al., “Synthesis , spectroscopic and DFT structural characterization of two novel ruthenium ( III ) oxicam complexes . In vivo evaluation of anti-in fl ammatory and gastric damaging activities,” J. Inorg. Biochem., vol. 134, pp. 25–35, 2014.
[14] G. Süss-Fink, “Water-soluble arene ruthenium complexes : From serendipity to catalysis and drug design,” J. Organomet. Chem., vol. 751, pp. 2–19, 2014.
[15] H. Küçükbay, S. Günal, E. Orhan, R. Durmaz, "Synthesis and antimicrobial activities of some transition metal benzimidazole complexes," Asian Journal of Chemistry, vol. 22, pp. 7376–7382, 2010.
[16] H. Küçükbay, R. Durmaz, E. Orhan, S. Günal, "Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds," Farmaco, vol. 58, pp. 431–437, 2003.
[17] Ü. Ergun, "ONO Ve ONNO Tipindeki Schiff Bazlarının Geçiş Metalleri Komplekslerinin Termal Bozunma Tepkimelerinde Kinetik Parametrelerinin Belirlenmesi ve Bazı Koordinasyon Bağ Enerjilerinin Hesaplanması, Doktora Tezi, Kimya ABD, Ankara Üniversitesi, Ankara, Türkiye, 2009.
[18] M. A. Bennett and A. K. Smith, “Arene Ruthenium ( II ) Complexes formed by Dehydrogenation of cyclo-hexadienes with ruthenium( III) trichloride,” pp. 233–241, 1974.
[19] N. P. E. Barry and B. Therrien, “Host-guest Chemistry in the Hexanuclear (arene)Ruthenium metalla-prismatic cage [Ru6(p-cymene)6(tpt)2(dhnq) 3]6+,” Eur. J. Inorg. Chem., vol. 6, pp. 4695–4700, 2009.
[20] H. Küçükbay, R. Durmaz, N. Okuyucu, S. Günal, and C. Kazaz, “ArzneimForschDrugRes Synthesis and Antibacterial Activities of New Bis-benzimidazoles,” Arzneim.-Forsch./Drug Res., vol. 54, no. 1, pp. 64–68, 2004.